Key Summary:

• A Perspective article proposed a framework linking REM sleep apnea to Alzheimer’s disease risk.
• REM-related hypoxemia was linked to cerebrovascular pathology and memory-related brain changes.
• Authors call for REM-specific sleep study indices to improve future risk stratification

REM SLEEP-RELATED sleep apnea may amplify the vascular processes that contribute to Alzheimer’s disease, according to a new framework linking sleep-disordered breathing during REM sleep to cerebrovascular damage and memory decline, particularly in older adults.

Sleep Apnea as an Overlooked Risk Factor for Alzheimer’s Disease

Obstructive sleep apnea has been recognized as a common though underdiagnosed disorder in older adults, and has been identified as a potential upstream vascular stressor linked to increased Alzheimer’s disease risk. Although the cardiometabolic and vascular consequences of sleep apnea have been increasingly studied, the specific contribution of rapid eye movement, or REM, sleep-related respiratory events to this relationship has remained underexplored.

The authors proposed a stage-informed framework synthesizing four linked lines of existing evidence: that REM sleep physiology magnifies the hypoxic and hemodynamic burden of obstructive sleep apnea; that the cardiometabolic consequences of sleep apnea are heightened during REM sleep; that REM-related hypoxemia is associated with markers of cerebrovascular pathology; and that vascular effects associated with REM-related hypoxemia are associated with medial temporal lobe vulnerability and memory dysfunction, both core features of Alzheimer’s disease.

REM-Related Hypoxemia Linked to Cerebrovascular and Memory Changes

REM-predominant obstructive sleep apnea was linked to elevated cardiometabolic risk, and markers of cerebrovascular pathology were linked to REM-related hypoxemia even after accounting for standard cardiovascular risk factors. Vascular pathways associated with REM-related hypoxemia were also linked to medial temporal lobe vulnerability, a brain region central to memory function and Alzheimer’s disease pathology. The authors noted that direct evidence linking REM-specific obstructive sleep apnea to Alzheimer’s disease biomarkers remained lacking, representing an evidence gap rather than a confirmed causal pathway.

Implications for Personalized Sleep Apnea Risk Assessment

These findings have suggested that reframing REM sleep as a window of cerebrovascular vulnerability could help refine risk stratification and personalize treatment for obstructive sleep apnea, particularly in older adults and those at elevated Alzheimer’s disease risk. As this was a perspective article synthesizing existing evidence rather than presenting new primary data, its conclusions represent a proposed framework rather than established causal findings. The authors have suggested that routine sleep study reporting should incorporate REM-specific indices to enable more precise phenotyping, even in patients whose overall apnea severity falls in the mild range.